Cargando…
Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
This cross-sectional study compares trends in prescribing buprenorphine to all Medicaid beneficiaries before and after the start of the COVID-19 pandemic.
Autores principales: | Dowd, William N., Mark, Tami L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948527/ https://www.ncbi.nlm.nih.gov/pubmed/35323952 http://dx.doi.org/10.1001/jamanetworkopen.2022.4058 |
Ejemplares similares
-
Buprenorphine Utilization and Prescribing Among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment Access
por: Treitler, Peter, et al.
Publicado: (2023) -
Comparison of Screening Mammogram Rates Before vs During the COVID-19 Pandemic Among Medicaid Beneficiaries in Louisiana
por: Shao, Yixue, et al.
Publicado: (2023) -
Housing insecurity of medicaid beneficiaries with cognitive disabilities during the COVID-19 pandemic
por: Friedman, Carli
Publicado: (2023) -
Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
por: Mark, Tami L., et al.
Publicado: (2020) -
Provision of School-based Preventive Oral Health Services to Medicaid Beneficiaries
por: Redmond, Anne R, et al.
Publicado: (2005)